Proyectos Europeos

Proyectos financiados por la Unión Europea

IRYCIS como miembro de plataformas europeas 

  • EATRIS - European Infrastructure for Translational Medicine.

  • ECRIN – European Clinical Research Infrastructure Network

Proyectos de la Iniciativa de Medicamentos Innovadores (IMI)

  • i-ABC: Inhaled Antibiotics in Bronchiectasias and Cystic Fibrosis (115721)
    Dr. Rafael Cantón

  • COMBACTE-CARE: Combatting bacterial resistence in EuropeCarbapenem Resistence (115620)
    Dr. Rafael Cantón 

  •  COMBACTE-NET (Combatting Bacterial Resistance in Europe): ARTHR-IS study: Retrospective study to identify the incidence, risk factors and outcomes of prosthetic joint infection due to Staphylococcus aureus after primary knee or hip joint replacement", con código FIS-MET-2019-01. Dr. Francisco J. Cobo Reinoso.

  • SPRINTT: Sarcopenia and physical frailty in older people: multi-component treatment strategies (115621-3)
    Dr. Alfonso J. Cruz-Jentoft

  • ENABLE: European Gram Negative Antibacterial Engine (115583)
    Dr. Fernando Baquero

  • 3TRIdentification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory and Allergic Conditions (831434).Dra. Luisa María Villar

  • CARDIATEAM: CARdiomyopathy in type 2 DIAbetes mellitus (821508)
    Dr. José Luis Zamorano


Proyectos del Séptimo Programa Marco (7PM)




  • MON4STRAT: Therapeutic Beta-Lactams Monitoring for Stratified and dose adjusted treatment of hospital-acquired pneumonia: improved efficacy, decreased treatment length, and reduction of emergence of resistance (602906-2)
    Dr. Rafael Cantón

  • SENATOR: Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and nondrug Therapy in Older peRsons (305930)
    Dr. Alfonso José Cruz-Jentoft

Proyectos de Horizonte 2020



  • CARBALIVE
    : Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease (634579) 
    Dr. Agustín Albillos
  • MyCyFAPP: Innovative approach for self-management and social welfare of cystic fi brosis patients in Europe: development, validation and implementation of a telematics tool (643806)
    Dra. María Garriga

  •        
    ImmunAID: Immunome project consortium for AutoInflammatory Disorders (779295) 
    Dra. Alina Lucica Boteanu
  • FAST-Bact: A novel fast and automated kit for antibiotic susceptibility testing for Gram positive and negative bacteria (730713)
    Dr. Rafael Cantón

  • Colodetect: Development of a novel bloodbased diagnostic test for colorectal cancer.
    Dr. Fernando Liaño García

  • BADGER: CalScreener® - an innovative device for bacterial analysis and diagnostics through growth and energy-release in real-time (784514)
    Dr. Rafael Cantón Moreno

  • NanoTBTech - Nanoparticles-based 2D thermal bioimaging technologies (801305) 
    Dr. Daniel Jaque Garcia

  • EATRIS-Plus - Consolidating the capacities of EATRIS-ERIC for Personalised Medicine (871096) 
    Dra. Laura García Bermejo

  • DECISION -  Decompensated cirrhosis: identification of new combinatorial therapies based on system approaches (847949) 
    Dr. Agustín Albillos

Ayudas Marie Curie

  • PurinesDX - Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases (766124)
    Dr. José Luis López-Sendón
     
  • REPLAY – Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance (895671)
    Dr. Alfonso Santos

Proyectos de la ERANET TRANSCAN

  • BioPac: Biomarkers of tumor recurrence in pancreatic cancer
    Dr. Alfredo Carrato
  • SCRAtCH: Microbiota-based screening of anal cancer in HIV-infected individuals
    Dr. Sergio Serrano Villar
  • NExT - Establishing an algorithm for the early diagnosis and follow-up of patients with pancreatic neuroendocrine tumors.
    Dr. Alfredo Carrato

Acciones COST

  • CliniMARK - Good biomarker practice (CA16113)
    Dra. Laura García Bermejo

  • TRANSAUTOPHAGY European Network for Multidisciplinary Research on Autophagy (CA15138)
    Dr. José Antonio Rodríguez Navarro

  • ENIUS - European network of multidisciplinary research to improve the urinary stents (CA16217)
    Dr. Javier Burgos y Dra. Victoria Gómez Dos Santos

Proyectos de la Iniciativa de Programación Conjunta en Resistencia Antimicrobiana (JPIAMR)

  • STARCS. Selection and Transmission of Antimicrobial Resistance in Complex Systems.
    Dra. Teresa Coque 
    + info
  • TRANSMISSION. Escherichia coli ST131: a model for high-risk.
    Dr. Fernando Baquero
    + info

  • NEAR-AMR. Network of European and African Researchers on Antimicrobial Resistance.
    Dra. María Teresa Coque
    + info

  • SOLIDNESS - Surveillance Of mobiLome meDiated aNtibiotic rEsiStance Spread.
    Dra. María Teresa Coque
    + info

Ayudas del Consejo Europeo de Investigación (ERC)

  • PLASREVOLUTION – Understanding the evolution of plasmid-mediated antibiotic resistance in real life scenarios (757440)

Proyectos EUROSTARS

  • HF-PREDICT - A Clinical Wearable System with Predictive Analytics for Heart Failure Managements 
    Dr. José Luis Zamorano

Proyectos EIT Health

  • PREDIRA - Prediction medical device for rheumatoid arthritis (19577)
    Dra. Mónica Vázquez 

  • CHRONIC PAIN - Electrical quantitative sensory assessment system for failed back surgery syndrome (20140)
    Dr. José Luis de la Calle

Ensayos clínicos en el seno de proyectos europeos 

  • EURECA Study (within COMBACTE CARE): European prospective cohort study on Enterobacteriaceae showing resistance to carbapenems (NCT02709408)
    Dr. Vicente Pintado
  • ANTICIPATE study (within COMBACTE NET): Assessment of the incidence of Clostridium difficile infections in hospitalized patients on antibiotic treatment (UMC-FLU-2016-01).
    Dr. Francisco Javier Cobo
  • ARTHR-IS study (within COMBACTE NET): Retrospective study to identify the incidence, risk factors and outcomes of prosthetic joint infection
    due to Staphylococcus aureus after primary knee or hip joint replacement", con código FIS-MET-2019-01. Dr. Francisco Javier Cobo
  • REVISIT study (within COMBACTE CARE): A Phase 3 prospective, randomized, multicenter, open label, central assessor blinded, parallel group, comparative study to determine the efficacy, safety and tolerability of aztreonam avibactam (ATM AVI) ±metronidazole (MTZ) versus meropenem±colistin (MER±COL) for the treatment of serious infections due to Gram negative bacteria, including metallo β lactamase (MBL) - producing multidrug resistant pathogens, for which there are limited or no treatment options. Dr. Francisco Javier Cobo

Proyectos cofinanciados con fondos europeos 

Proyectos Mineco+Feder